Guardian Pharmacy Services, Inc. (NYSE:GRDN) Short Interest Up 58.2% in September

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 536,600 shares, a growth of 58.2% from the August 31st total of 339,200 shares. Based on an average daily volume of 288,200 shares, the short-interest ratio is currently 1.9 days. Currently, 2.8% of the shares of the stock are short sold. Currently, 2.8% of the shares of the stock are short sold. Based on an average daily volume of 288,200 shares, the short-interest ratio is currently 1.9 days.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Weiss Ratings restated a "sell (d+)" rating on shares of Guardian Pharmacy Services in a research report on Saturday, September 27th. Wall Street Zen cut Guardian Pharmacy Services from a "strong-buy" rating to a "buy" rating in a research report on Friday. Finally, Truist Financial raised their price target on Guardian Pharmacy Services from $28.00 to $30.00 and gave the stock a "buy" rating in a research report on Friday, September 26th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $26.33.

Institutional Trading of Guardian Pharmacy Services

Large investors have recently bought and sold shares of the business. GAMMA Investing LLC acquired a new stake in Guardian Pharmacy Services in the first quarter valued at about $170,000. New York State Common Retirement Fund boosted its stake in Guardian Pharmacy Services by 16.1% in the first quarter. New York State Common Retirement Fund now owns 323,257 shares of the company's stock valued at $6,872,000 after buying an additional 44,709 shares in the last quarter. Woodline Partners LP boosted its stake in Guardian Pharmacy Services by 1.5% in the first quarter. Woodline Partners LP now owns 421,203 shares of the company's stock valued at $8,955,000 after buying an additional 6,083 shares in the last quarter. Peregrine Capital Management LLC boosted its stake in shares of Guardian Pharmacy Services by 56.1% during the first quarter. Peregrine Capital Management LLC now owns 176,539 shares of the company's stock valued at $3,753,000 after purchasing an additional 63,464 shares in the last quarter. Finally, Calamos Advisors LLC boosted its stake in shares of Guardian Pharmacy Services by 61.5% during the first quarter. Calamos Advisors LLC now owns 39,919 shares of the company's stock valued at $849,000 after purchasing an additional 15,194 shares in the last quarter.

Guardian Pharmacy Services Stock Down 2.1%

NYSE:GRDN opened at $23.92 on Monday. The stock's 50-day simple moving average is $25.02 and its 200 day simple moving average is $23.05. The firm has a market capitalization of $1.51 billion and a PE ratio of -15.73. Guardian Pharmacy Services has a twelve month low of $16.50 and a twelve month high of $30.39.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.